| 1897-05-14 |
Founded in 1897 by 21 influential pharmaceutical entrepreneurs in Osaka, Dosho-machi, Osaka Seiyaku Co., Ltd. was established. |
| 1898 |
Established a pharmaceutical factory in Ebie, Osaka (Old Osaka Factory, Old Osaka General Center). |
| 1898 |
Absorbed and merged the semi-governmental, semi-private Dainippon Seiyaku Company in Tokyo and renamed it Dainippon Seiyaku Co., Ltd. |
| 1898 |
Established pharmaceutical factory in Ebie, Osaka (Old Osaka Factory, Old Osaka General Center); merged with semi-governmental Dainippon Seiyaku Company in Tokyo and renamed Dainippon Seiyaku Co., Ltd. |
| 1908 |
Merged Osaka Pharmaceutical Testing Co., Ltd. |
| 1914 |
Started chemical product business. |
| 1914 |
Started chemical product business. |
| 1927 |
Launched new bronchodilator and cough suppressant "Ephedrine 'Nagawi®'". |
| 1927 |
Launched new bronchodilator and cough suppressant "Ephedrine 'Nagawi®'". |
| 1944 |
Sumitomo Chemical Industries, Ltd. (now Sumitomo Chemical Co., Ltd.) entered the pharmaceutical business. |
| 1944 |
In 1944, Sumitomo Chemical Industries, Ltd. (now Sumitomo Chemical Co., Ltd.) entered the pharmaceutical business. |
| 1950 |
Started animal drug business. |
| 1950 |
Started animal drug business. |
| 1956 |
Started over-the-counter drug business. |
| 1956 |
Started over-the-counter drug business. |
| 1960 |
Started food additive business. |
| 1960 |
Started food additive business. |
| 1961 |
Sumitomo Chemical Industries, Ltd. launched chloroquine preparations (Kynuron). |
| 1961 |
In 1961, Sumitomo Chemical Industries, Ltd. launched chloroquine preparations (Kynuron); see the section on chloroquine drug damage incident. |
| 1962 |
Voluntarily withdrew thalidomide preparations (Isomin launched in 1958, Proban M launched in 1960). |
| 1962 |
Voluntarily withdrew thalidomide preparations (Isomin launched in 1958, Proban M launched in 1960). |
| 1963 |
Established Dainippon Pharmaceutical in Taiwan. |
| 1963 |
Established Taiwan Dainippon Pharmaceutical. |
| 1968 |
Set up Suzuka Factory in Suzuka City, Mie Prefecture. |
| 1968 |
Established Suzuka Factory in Suzuka City, Mie Prefecture. |
| 1970 |
Completed the General Research Institute in Suita, Osaka. |
| 1970 |
Completed the General Research Institute in Suita, Osaka. |
| 1974 |
Started laboratory products business. |
| 1974 |
Started laboratory products business. |
| 1979 |
Launched new antimicrobial chemotherapeutic "Dorcool®". |
| 1979 |
Launched new antimicrobial chemotherapeutic "Dorcool®". |
| 1984-02-06 |
Inheriting research, development, and manufacturing divisions of Sumitomo Chemical Industries' pharmaceutical business, and the pharmaceutical sales division of Inabata Sangyo Co., Ltd., the general agent for Sumitomo Chemical's pharmaceuticals, Sumitomo Pharmaceutical Co., Ltd. was established in February 1984 and began operations on October 1 of the same year. |
| 1984-02-06 |
In 1984, on February 6, Sumitomo Pharmaceutical Co., Ltd. was established inheriting research, development, and manufacturing divisions of Sumitomo Chemical Industries' pharmaceutical business and the pharmaceutical sales division of Inabata Sangyo Co., Ltd., the general agent for Sumitomo Chemical's pharmaceuticals, and began operations on October 1 of the same year; launched transdermal analgesic and anti-inflammatory "Inteban® Cream" and cephalosporin antibiotic "Sepatren®". |
| 1984-02-06 |
Inheriting research, development, and manufacturing divisions of Sumitomo Chemical Industries' pharmaceutical business, and the pharmaceutical sales division of Inabata Sangyo Co., Ltd., the general agent for Sumitomo Chemical's pharmaceuticals, Sumitomo Pharmaceutical Co., Ltd. was established. |
| 1984-10-01 |
Sumitomo Pharmaceutical Co., Ltd. commenced sales. |
| 1985 |
Completed Ehime Bio-Factory. |
| 1985 |
Launched new antihypertensive, angina, and arrhythmia treatment "Almar® Tablets". |
| 1985 |
In 1985, completed Ehime Bio-Factory and launched new antihypertensive, angina, and arrhythmia treatment "Almar® Tablets". |
| 1987 |
Established Epilepsy Treatment Research Promotion Foundation. |
| 1987 |
Launched natural interferon-alpha preparation "Sumiferon®". |
| 1987 |
In 1987, launched natural interferon-alpha preparation "Sumiferon®". |
| 1987 |
Established Epilepsy Treatment Research Promotion Foundation. |
| 1988 |
Opened U.S. office. |
| 1988 |
Launched new peripheral circulation enhancer "Prolena®". |
| 1988 |
Launched sustained-release ACE inhibitor antihypertensive "Cetanpril®". |
| 1988 |
Opened U.S. office, launched new peripheral circulation enhancer "Prolena®", and new ACE inhibitor antihypertensive "Cetanpril®". |
| 1989 |
Launched new anticonvulsant "Exegran®". |
| 1989 |
Launched norepinephrine-acting nerve function enhancer "Dops®". |
| 1989 |
Launched new anticonvulsant "Exegran®". |
| 1989 |
In 1989, launched norepinephrine-acting nerve function enhancer "Dops®". |
| 1990 |
Launched bone metabolism enhancer "Daidronel®". |
| 1990 |
In 1990, launched bone metabolism enhancer "Daidronel®". |
| 1991 |
Completed Osaka Product Center. |
| 1993 |
Completed the Central Logistics Center (current Kobe Logistics Center). |
| 1993 |
Transferred feed additive business. |
| 1993 |
Launched new antihypertensive and angina drug "Amrozin®". |
| 1993 |
Completed the Central Logistics Center (current Kobe Logistics Center). |
| 1993 |
In 1993, transferred feed additive business and launched new antihypertensive and angina drug "Amrozin®". |
| 1995 |
Launched carbapenem antibiotic "MeroPen®". |
| 1995 |
In 1995, launched carbapenem antibiotic "MeroPen®". |
| 1996 |
Launched new sustained anti-allergy agent "Evastel®". |
| 1996 |
Launched new serotonin-acting anxiolytic "Sederil®". |
| 1996 |
Launched new sustained anti-allergy agent "Evastel®". |
| 1996 |
In 1996, launched serotonin-acting anxiolytic "Sederil®". |
| 1997 |
Celebrated 100th anniversary. |
| 1997 |
Completed new Tokyo Product Center (current Tokyo Logistics Center), established Sumitomo Pharma UK Limited, and opened Beijing office. |
| 1997 |
In 1997, completed new Tokyo Product Center (current Tokyo Logistics Center), established Sumitomo Pharma UK Limited, and opened Beijing office. |
| 1997 |
Celebrated 100th anniversary. |
| 1997 |
Completed new Tokyo Product Center (current Tokyo Logistics Center). |
| 1997 |
Established Sumitomo Pharma UK Limited. |
| 1997 |
Opened Beijing office. |
| 1998 |
Opened offices in London and Beijing. |
| 1998 |
Launched new gastrointestinal motility enhancer "Gasmochin®". |
| 1998 |
Opened offices in London and Beijing; launched new gastrointestinal motility enhancer "Gasmochin®". |
| 1998 |
Opened offices in London and Beijing; launched new gastrointestinal motility enhancer "Gasmochin®". |
| 1999 |
Launched new cancer pain treatment "Kadian®". |
| 1999 |
Launched recombinant human growth hormone "Growject®", transferred animal drug business, and established Sumitomo Pharma America Limited. |
| 1999 |
Launched new cancer pain treatment "Kadian®". |
| 1999 |
In 1999, launched recombinant human growth hormone "Growject®", transferred animal drug business, and established Sumitomo Pharma America Limited. |
| 1999 |
Launched recombinant human growth hormone "Growject®". |
| 1999 |
Transferred animal drug business. |
| 1999 |
Established Sumitomo Pharma America Limited. |
| 2000 |
Transferred active pharmaceutical ingredient business and started sales of sterilizer "Hibiten®". |
| 2000 |
In 2000, transferred active pharmaceutical ingredient business and started sales of sterilizer "Hibiten®". |
| 2000 |
Transferred active pharmaceutical ingredient business. |
| 2000 |
Started sales of sterilizer "Hibiten®". |
| 2001 |
Launched antipsychotic "Rulan®" and started sales of H2 receptor antagonist "Tagamet®"; began operations of Sumitomo Pharma Biomed Co., Ltd. |
| 2001 |
In 2001, launched antipsychotic "Rulan®" and started sales of H2 receptor antagonist "Tagamet®"; began operations of Sumitomo Pharma Biomed Co., Ltd. |
| 2001 |
Launched antipsychotic "Rulan®". |
| 2001 |
Started sales of H2 receptor antagonist "Tagamet®". |
| 2001 |
Started operations of Sumitomo Pharma Biomed Co., Ltd. |
| 2002 |
Launched inhaled steroid asthma treatment "Qubair™". |
| 2002 |
Launched inhaled steroid asthma treatment "Qubair™". |
| 2003 |
Closed Osaka Factory and integrated into Suzuka Factory. |
| 2003 |
Launched new oral cancer pain treatment "Opso®". |
| 2003 |
Inherited active pharmaceutical ingredient manufacturing from Sumitomo Chemical and established Oita Factory. |
| 2003 |
Closed Osaka Factory (integrated into Suzuka Factory); launched new oral cancer pain treatment "Opso®". |
| 2003 |
Closed Osaka Factory (integrated into Suzuka Factory); launched new oral cancer pain treatment "Opso®". |
| 2004 |
Celebrated 20th anniversary of operations. |
| 2004 |
In 2004, celebrated 20th anniversary of operations. |
| 2005 |
Transferred over-the-counter drug business. |
| 2005 |
Launched new sustained-release H1 receptor antagonist "Evastel® OD Tablets". |
| 2005 |
Transferred over-the-counter drug business; launched new sustained-release H1 receptor antagonist "Evastel® OD Tablets". |
| 2005 |
In 2005, transferred over-the-counter drug business. |
| 2005 |
Transferred over-the-counter drug business; launched new sustained-release H1 receptor antagonist "Evastel® OD Tablets". |
| 2005-10 |
Sumitomo Pharma was formed in October 2005 through the merger of Dainippon Pharmaceutical Co., Ltd. and Sumitomo Pharmaceutical Co., Ltd. |
| 2005-10 |
Celebrated 20th anniversary of operations. |
